# TherapeuticsMD, Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 10-K/A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 17:00 ET
- Period: 2024-12-31
- Accession: 0001213900-25-037713
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000121390025037713/ea0239596-10ka1_therapeutics.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000121390025037713/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000121390025037713/ea0239596-10ka1_therapeutics.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-037713. Last ingested by Listed: Oct 24, 2026, 14:52 ET. No prices; not investment advice.